- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 14 x CLR: CHOLESTEROL(Non-covalent)
- 6 x 3PE: 1,2-Distearoyl-sn-glycerophosphoethanolamine(Non-covalent)
3PE.2: 25 residues within 4Å:- Chain A: L.278, F.281, L.282, L.285, T.289, H.299, F.303, L.305, N.306, S.309, N.310, L.311, L.316, L.323, Y.352, M.355, L.359, K.369, S.370, W.373, L.374, W.395, L.400, I.406, L.410
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:L.278, A:L.282, A:L.285, A:F.303, A:L.323, A:Y.352, A:M.355, A:L.359, A:W.373, A:W.373, A:L.374, A:L.374, A:W.395, A:W.395, A:L.400, A:I.406, A:L.410
- Hydrogen bonds: A:K.369
- Salt bridges: A:H.299
3PE.3: 19 residues within 4Å:- Chain A: I.243, T.250, L.326, L.329, L.332, A.333, F.336, P.338, Y.347, L.351, F.354
- Chain B: I.249, T.250, L.253, F.257
- Ligands: CLR.5, LPE.10, PLM.11, 3PE.14
16 PLIP interactions:4 interactions with chain B, 12 interactions with chain A- Hydrophobic interactions: B:I.249, B:I.249, B:T.250, B:L.253, A:I.243, A:I.243, A:T.250, A:L.326, A:L.329, A:L.332, A:A.333, A:F.336, A:F.336, A:P.338, A:Y.347, A:F.354
3PE.7: 15 residues within 4Å:- Chain A: P.228, A.229, C.241, F.244, N.248, I.249, F.283, I.287, Y.290, H.313, Q.314, F.317
- Chain B: A.231, W.232, F.235
10 PLIP interactions:9 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:F.244, A:I.249, A:F.283, A:I.287, A:Y.290, A:Y.290, B:W.232
- Hydrogen bonds: A:A.229, A:Q.314
- Salt bridges: A:H.313
3PE.14: 19 residues within 4Å:- Chain A: I.249, T.250, L.253, F.257
- Chain B: I.243, T.250, L.326, L.329, L.332, A.333, F.336, P.338, Y.347, L.351, F.354
- Ligands: 3PE.3, CLR.18, LPE.23, PLM.24
16 PLIP interactions:12 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:I.243, B:I.243, B:T.250, B:L.326, B:L.329, B:L.332, B:A.333, B:F.336, B:F.336, B:P.338, B:Y.347, B:F.354, A:I.249, A:I.249, A:T.250, A:L.253
3PE.16: 23 residues within 4Å:- Chain B: L.278, F.281, L.285, T.289, H.299, F.303, L.305, N.306, S.309, N.310, L.311, L.323, Y.352, M.355, L.359, K.369, S.370, W.373, L.374, W.395, L.400, I.406, L.410
19 PLIP interactions:19 interactions with chain B- Hydrophobic interactions: B:L.278, B:L.285, B:F.303, B:L.323, B:Y.352, B:M.355, B:L.359, B:L.359, B:W.373, B:W.373, B:L.374, B:L.374, B:W.395, B:W.395, B:L.400, B:I.406, B:L.410
- Hydrogen bonds: B:K.369
- Salt bridges: B:H.299
3PE.20: 15 residues within 4Å:- Chain A: A.231, W.232, F.235
- Chain B: P.228, A.229, C.241, F.244, N.248, I.249, F.283, I.287, Y.290, H.313, Q.314, F.317
10 PLIP interactions:9 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:F.244, B:I.249, B:F.283, B:I.287, B:Y.290, B:Y.290, A:W.232
- Hydrogen bonds: B:A.229, B:Q.314
- Salt bridges: B:H.313
- 2 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
LPE.10: 14 residues within 4Å:- Chain A: R.236, L.239, F.240, E.318, F.322, I.325, L.329, F.354, T.365, F.366, Y.367
- Ligands: 3PE.3, CLR.5, PLM.11
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:L.239, A:F.240, A:I.325, A:L.329, A:F.354
- Salt bridges: A:R.236, A:E.318
- pi-Cation interactions: A:F.322, A:F.366
LPE.23: 14 residues within 4Å:- Chain B: R.236, L.239, F.240, E.318, F.322, I.325, L.329, F.354, T.365, F.366, Y.367
- Ligands: 3PE.14, CLR.18, PLM.24
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:L.239, B:F.240, B:I.325, B:L.329, B:F.354
- Salt bridges: B:R.236, B:E.318
- pi-Cation interactions: B:F.322, B:F.366
- 2 x PLM: PALMITIC ACID(Non-covalent)
PLM.11: 6 residues within 4Å:- Chain A: W.232, F.235, R.236
- Chain B: I.245
- Ligands: 3PE.3, LPE.10
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:W.232, A:F.235, B:I.245
- Salt bridges: A:R.236
PLM.24: 6 residues within 4Å:- Chain A: I.245
- Chain B: W.232, F.235, R.236
- Ligands: 3PE.14, LPE.23
4 PLIP interactions:3 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:W.232, B:F.235, A:I.245
- Salt bridges: B:R.236
- 2 x ACD: ARACHIDONIC ACID(Non-covalent)
ACD.13: 5 residues within 4Å:- Chain A: R.263, S.264, I.265, W.266, P.598
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:I.265, A:P.598
ACD.26: 5 residues within 4Å:- Chain B: R.263, S.264, W.266, P.598, L.599
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:P.598, B:L.599
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zuo, P. et al., Synergistic activation of the human phosphate exporter XPR1 by KIDINS220 and inositol pyrophosphate. Nat Commun (2025)
- Release Date
- 2025-04-02
- Peptides
- Solute carrier family 53 member 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 14 x CLR: CHOLESTEROL(Non-covalent)
- 6 x 3PE: 1,2-Distearoyl-sn-glycerophosphoethanolamine(Non-covalent)
- 2 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 2 x PLM: PALMITIC ACID(Non-covalent)
- 2 x ACD: ARACHIDONIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zuo, P. et al., Synergistic activation of the human phosphate exporter XPR1 by KIDINS220 and inositol pyrophosphate. Nat Commun (2025)
- Release Date
- 2025-04-02
- Peptides
- Solute carrier family 53 member 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
A - Membrane
-
We predict this structure to be a membrane protein.